INVARIANT LLC for CIGNA CORPORATION
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Discuss issues related to legislation to repeal a 40 percent ACA excise tax on certain employer-sponsored health insurance plans; S. 172 / H.R. 1398, the Health Insurance Tax (HIT) Relief Act of 2019 (legislation to suspend the ACA's health insurance tax (HIT) in 2020 and 2021); and S.80, Jobs and Premium Protection Act (full repeal of the HIT).
| Lobbyist | Covered position, as disclosed |
|---|---|
| BENJAMIN KLEIN | — |
| KATHRYN WISE | — |
Health Issues HCR
Discuss issues relating to P.L. 111-148, the Patient Protection and Affordable Care Act, and P.L. 111-152, the Health Care and Education Reconciliation Act, including exchanges, cost sharing reduction, market reforms and coverage expansion proposals, and non-discrimination provisions; and S. 1895, the Lower Health Care Costs Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BENJAMIN KLEIN | — |
| KATHRYN WISE | — |
Medicare/Medicaid MMM
Discuss issues related to ongoing implementation of payment and regulatory issues for the Medicare Advantage program; drug pricing legislation, including H.R. 3, the Lower Drug Costs Now Act of 2019, and S. 2543, the Prescription Drug Pricing Reduction Act of 2019; proposals that impact Medicare Part D such as formulary requirements, pharmacy benefit manager (PBM) disclosure provisions, closing the Part D coverage gap, and direct negotiation of prescription drug prices.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BENJAMIN KLEIN | — |
| KATHRYN WISE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.